26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Recurrence of Paraneoplastic Membranous Glomerulonephritis Following Chemoradiation in a Man With Non-Small-Cell Lung Carcinoma

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract

          Membranous glomerulonephritis can occur as a rare paraneoplastic complication of human cancers. In this case report, we describe a patient who presented acutely with symptoms of the nephrotic syndrome including heavy proteinuria and anasarca. He was subsequently diagnosed with membranous glomerulonephritis, and soon afterwards was found to have stage IIIB non-small cell lung cancer. Following chemoradiation therapy, both the patient’s cancer and membranous glomerulonephritis dramatically improved. However, approximately 14 months following his initial presentation, the patient was found to have a recurrence of his nephrotic-range proteinuria which corresponded temporally with recurrence of his cancer. We present details of the case and a review of the relevant scientific literature.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.

          The association between membranous nephropathy (MN) and cancer is often mentioned in textbooks but poorly substantiated, and the characteristics of cancer-associated MN are unknown. To address these questions, we studied a cohort of 240 patients with MN, among them 24 had malignancy at the time of renal biopsy or within a year thereafter. The incidence of cancer was significantly higher in these patients than in the general population (standardized incidence ratio 9.8 [5.5-16.2] for men and 12.3 [4.5-26.9] for women). The frequency of malignancy increased with age. At the time of diagnosis, clinical presentation did not differ between the patients with cancer-associated MN and those with idiopathic MN, but smoking was more frequent among patients with cancer. Analysis of renal biopsies revealed that the number of inflammatory cells infiltrating the glomeruli was significantly higher in patients with cancer-associated MN (P = 0.001). The best cutoff value for distinguishing malignancy-related cases from controls was eight cells per glomerulus. Using this threshold led to a diagnosis of cancer-associated MN with a specificity of 75% and a sensitivity of 92%. In patients with cancer-associated MN, there was a strong relationship between reduction of proteinuria and clinical remission of cancer (P < 0.001). In conclusion, our study provides epidemiologic evidence of an excess of cancer risk in patients with MN. It also shows that age, smoking, and the presence of glomerular leukocytic infiltrates strongly increase the likelihood of malignancy in MN patients.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Paraneoplastic glomerulopathies: new insights into an old entity.

            P Ronco (1999)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Glomerulopathies of neoplasia.

              J Eagen (1977)
                Bookmark

                Author and article information

                Journal
                Rare Tumors
                Rare Tumors
                RT
                Rare Tumors
                PAGEPress Publications
                2036-3605
                2036-3613
                06 May 2013
                15 April 2013
                : 5
                : 2
                : 62-64
                Affiliations
                Departments of [1 ] Radiation Oncology
                [2 ]Nephrology
                [3 ]Hematology/Oncology, Alpert Medical School of Brown University , Providence, RI, USA
                Author notes
                Alpert Medical School of Brown University, Department of Radiation Oncology, Rhode Island Hospital, 593 Eddy Street Providence, RI 02903, USA. E-mail: jhepel@ 123456lifespan.org
                Contributions: ARC wrote the manuscript and made substantial contributions to the conception and design of this report and to data analysis. LD, KL, and HK provided data analysis and provided critical review of the manuscript for important intellectual content. JTH assisted with writing the manuscript and made substantial contributions to the conception and design of this report and to data analysis.
                Conflict of interests: the authors declare no potential conflict of interests.
                This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BYNC 3.0).
                Article
                10.4081/rt.2013.e16
                3719111
                23888216
                adea0472-66a0-4cd8-8cfc-9d68a4634eef
                ©Copyright A.R. Crawford et al.,
                History
                : 14 October 2012
                : 16 January 2013
                : 19 December 2012
                Page count
                Figures: 3, Tables: 0, Equations: 0, References: 18, Pages: 3
                Categories
                Case Report

                Oncology & Radiotherapy
                paraneoplastic syndrome,nephrotic syndrome
                Oncology & Radiotherapy
                paraneoplastic syndrome, nephrotic syndrome

                Comments

                Comment on this article